Last reviewed · How we verify
Aminoacetic Acid 1.5% In Plastic Container (GLYCINE)
At a glance
| Generic name | GLYCINE |
|---|---|
| Sponsor | Baxter |
| Drug class | glycine |
| Target | Olfactory receptor 51E2 |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
| First approval | 1976 |
Approved indications
- Allergic rhinitis
- Common cold
- Cough
- Nasal congestion
- Nasal discharge
- Rhinitis
Common side effects
Key clinical trials
- Decontamination Methods in the Treatment of Peri-implantitis (NA)
- Glutathione in Mild Cognitive Impairment (EARLY_PHASE1)
- Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes (PHASE4)
- A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M (PHASE2)
- Effects of Habitual Water Intake on Thirst in Healthy Young Adults Explained by Osmoadaptive Metabolism, Brain and Kidney Function (Adapt-Thirst) (NA)
- Comparative Analysis of Analgesic Approaches in the Early Period After CABG (NA)
- The Effects of Acupressure and Massage Following Cesarean Section (NA)
- Trehalose vs Glycine Air-Polishing in Peri-Implant Mucositis Treatment (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |